Norac Pharma – Emissions Trend

Azusa, CA · 2021–2022 · Parent: S & B Pharma DBA Norac Pharma

This page assembles 2 consecutive years of EPA Toxics Release Inventory Form R filings for Norac Pharma, spanning 2021–2022. Each annual total aggregates on-site air emissions, surface-water discharges, land disposal, and off-site transfers reported by the facility under EPCRA Section 313, which requires disclosure whenever a listed chemical is manufactured, processed, or otherwise used above threshold quantities.

Reported releases opened at 500 in 2021 and closed at 220 in 2022 – a decrease of 56.0% over the window. The chart below stacks the four TRI release media (air, water, land, off-site) and overlays the yearly total. The top contributor by cumulative mass is Methanol at 720.

Because TRI figures are estimated, not metered, year-over-year deltas can reflect methodology revisions, ownership changes, or shifts in what a facility classifies as reportable, not only physical emission changes. Treat the trajectory as a disclosure record, and cross-reference with the EPA Enforcement and Compliance History Online (ECHO) system for the fuller regulatory picture on this chemicals facility.

Overall Trend
↓ Decreasing (-56.0%)
2021 Total
500 lbs
2022 Total
220 lbs

Total Releases by Category

Air
Water
Land
Offsite Transfer
0100200300400500 20212022 Pounds Released

Year-over-Year Comparison

Year Total Chemicals YoY Change
2021 500 lbs 1 -
2022 220 lbs 1 -56.0%

Top Chemicals by Year

Chemical 20212022 Total
Methanol 500 220 720

About This Data

Trend data is sourced from the EPA Toxic Release Inventory (TRI). Facilities report annually. Release quantities are self-reported estimates. Year-over-year changes may reflect changes in production, pollution control measures, reporting methodology, or chemical thresholds.

A decrease in reported releases does not necessarily indicate improved environmental performance, as it may reflect production cutbacks, facility closures, or changes in reporting requirements. Similarly, increases may reflect expanded production rather than degraded environmental practices.

Frequently Asked Questions

Is Norac Pharma getting cleaner or dirtier?
Based on EPA TRI data from 2021–2022, Norac Pharma's total toxic releases have decreased by approximately 56%.
What time period does this trend data cover?
This page shows 2 years of EPA Toxic Release Inventory data from 2021–2022. Release quantities are self-reported estimates filed annually by the facility.